Study to evaluate the effect of CIN-107 on the pharmacokinetics of the MATE substrate, Metformin, in Healthy Subjects

Trial Identifier:	CIN-107-114
Sponsor:	AstraZeneca
NCTID::	NCT05526690
Start Date:	October 2020
Primary Completion Date:	December 2020
Study Completion Date:	December 2020
Condition:	Hypertension

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
United States, Ohio	Cincinnati, Ohio, United States, 45227

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.